Valeria Rolih

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy

M. Arigoni, P. Buracco, L. Conti, 2018, International journal of molecular sciences.

Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.

L. Conti, F. Cavallo, Elisabetta Bolli, 2019, Progress in molecular biology and translational science.

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo

F. Pericle, S. Lanzardo, L. Conti, 2017, Oncoimmunology.

CSPG4: a prototype oncoantigen for translational immunotherapy studies

P. Buracco, F. Cavallo, F. Riccardo, 2017, Journal of Translational Medicine.

Animal Models for Translational Cancer Immunotherapy Studies

F. Cavallo, F. Riccardo, V. Rolih, 2016 .

Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells

G. Donofrio, S. Lanzardo, L. Conti, 2018, Oncoimmunology.

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter

G. Donofrio, F. Pericle, L. Conti, 2018, Cancer Immunology, Immunotherapy.

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+ mammary cancer

S. Ottonello, V. Franceschi, G. Donofrio, 2015, Oncoimmunology.